FR1228811A - Composition auto-propulsante pour la distribution de poudre - Google Patents

Composition auto-propulsante pour la distribution de poudre

Info

Publication number
FR1228811A
FR1228811A FR756970A FR756970A FR1228811A FR 1228811 A FR1228811 A FR 1228811A FR 756970 A FR756970 A FR 756970A FR 756970 A FR756970 A FR 756970A FR 1228811 A FR1228811 A FR 1228811A
Authority
FR
France
Prior art keywords
self
powder distribution
propelling composition
propelling
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR756970A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Riker Laboratories Inc
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Application granted granted Critical
Publication of FR1228811A publication Critical patent/FR1228811A/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A01N25/06—Aerosols
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
    • C11D17/0043—For use with aerosol devices

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Materials Engineering (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Otolaryngology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Medicinal Preparation (AREA)
FR756970A 1957-01-31 1958-01-29 Composition auto-propulsante pour la distribution de poudre Expired FR1228811A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63735357A 1957-01-31 1957-01-31
US68001657A 1957-08-23 1957-08-23
US706908A US3014844A (en) 1957-01-31 1958-01-03 Self-propelling powder dispensing compositions

Publications (1)

Publication Number Publication Date
FR1228811A true FR1228811A (fr) 1960-09-02

Family

ID=22180422

Family Applications (1)

Application Number Title Priority Date Filing Date
FR756970A Expired FR1228811A (fr) 1957-01-31 1958-01-29 Composition auto-propulsante pour la distribution de poudre

Country Status (6)

Country Link
US (1) US3014844A (fr)
BE (1) BE556587A (fr)
DE (1) DE1178975B (fr)
FR (1) FR1228811A (fr)
GB (1) GB837465A (fr)
NL (2) NL106832C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170909B (de) * 1961-02-17 1964-05-27 Specialties Dev Corp Selbsttreibendes Gemisch
FR2424740A1 (fr) * 1978-02-06 1979-11-30 Fresenius Chem Pharm Ind Sels metalliques de sulfadiazine en fines particules, leur procede de preparation et preparations pharmaceutiques les contenant

Families Citing this family (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3124505A (en) * 1964-03-10 Aerosol concentrates containing a sta-
US3155573A (en) * 1958-05-06 1964-11-03 Benger Lab Ltd Inhalant composition and method of making same
US3076745A (en) * 1958-11-17 1963-02-05 Poultry Service And Res Corp Antibiotic method for promoting poultry growth
US3079299A (en) * 1959-11-16 1963-02-26 Gen Aerosol Corp Self-propelling medicinal ointment composition containing polyethylene and method ofapplication
US3088874A (en) * 1960-05-23 1963-05-07 Union Carbide Corp Powder aerosol
US3135658A (en) * 1961-10-10 1964-06-02 Merck & Co Inc Non-aqueous oleaginous aerosol foam therapy of bovine mastitis
US3095355A (en) * 1961-10-12 1963-06-25 Revlon Aerosol composition
GB1013386A (fr) * 1962-05-01
BE632504A (fr) * 1962-05-24
US3169095A (en) * 1962-10-30 1965-02-09 Rexall Drug Chemical Self-propelling powder-dispensing compositions
BE629985A (fr) * 1962-11-29
US3345295A (en) * 1963-02-13 1967-10-03 Shulton Inc Copper cleaning compositions
US3304230A (en) * 1963-02-18 1967-02-14 Revlon Liquid aerosol propellant solutions of fatty acid salts of physiologically active amines
US3446892A (en) * 1963-09-18 1969-05-27 Whitmire Research Lab Inc Immobilizing insects by sudden reduction of body temperature
US3260408A (en) * 1964-04-08 1966-07-12 Bell & Howell Co Method and means of dispersing particulate material in a stream of carrier fluid
US3282791A (en) * 1965-08-17 1966-11-01 Merck & Co Inc Inhalation aerosol suspension of anhydrous disodium dexamethasone phosphate, propellents, and sorbitan trioleate
US3968203A (en) * 1965-10-01 1976-07-06 Jerome G. Spitzer Aerosol astringent composition
US3402665A (en) * 1966-08-15 1968-09-24 Aeroprojects Inc Nonpyrotechnic disseminator
US4027007A (en) * 1970-12-09 1977-05-31 Colgate-Palmolive Company Antiperspirants formulated with borax
GB1429184A (en) * 1972-04-20 1976-03-24 Allen & Hanburys Ltd Physically anti-inflammatory steroids for use in aerosols
US4411883A (en) * 1973-02-05 1983-10-25 Colgate-Palmolive Company Antiperspirant
US3923971A (en) * 1973-09-13 1975-12-02 Alexandre Seilinger Antiperspirant and deodorant composition containing lamellar substances
US4010252A (en) * 1974-12-19 1977-03-01 Colgate-Palmolive Company Antimicrobial compositions
US4192766A (en) * 1975-04-25 1980-03-11 United Chemical Corporation Composition for decreasing water resistance to movement
IL51314A (en) * 1976-01-30 1980-03-31 Fisons Ltd Disodium cromoglycate of low moisture content and pharmaceutical compositions containing it
US4147766A (en) * 1976-06-09 1979-04-03 Armour Pharmaceutical Company Macrospherical particles of anti-perspirants
AU522792B2 (en) * 1977-07-19 1982-06-24 Fisons Plc Pressure pack formulation
JPS5529524A (en) * 1978-08-21 1980-03-01 Toyo Aerosol Kogyo Kk Powdery aerosol composition
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
CA1178889A (fr) * 1980-08-28 1984-12-04 Kenneth S. Su Produit pharmaceutique administre par voie intranasale
JPS59163313A (ja) * 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
DE3326089A1 (de) * 1983-07-20 1985-02-07 Gödecke AG, 1000 Berlin Zur inhalation bestimmte darreichungsform von calcium-antagonisten
ZA852884B (en) * 1984-04-25 1986-11-26 Lilly Co Eli Sustained release intranasal formulation and method of use thereof
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
FI913899A7 (fi) * 1989-02-23 1991-08-19 Rorer Int Holdings Inc Terapeuttiset aerosoliseokset
GB8921222D0 (en) * 1989-09-20 1989-11-08 Riker Laboratories Inc Medicinal aerosol formulations
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) * 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
MX9203481A (es) * 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
IL104068A (en) 1991-12-12 1998-10-30 Glaxo Group Ltd Surfactant-free pharmaceutical aerosol formulation comprising 1,1,1,2-tetrafluoroethane or 1,1,1,2,3,3,3-heptafluoro-n- propane as propellant
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5653962A (en) * 1991-12-12 1997-08-05 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
ATE128350T1 (de) * 1991-12-12 1995-10-15 Glaxo Group Ltd Pharmazeutische aerosolformulierung.
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
CA2421976C (fr) 1991-12-12 2004-04-20 Glaxo Group Limited Medicaments
US7105152B1 (en) 1991-12-18 2006-09-12 3M Innovative Properties Company Suspension aerosol formulations
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
ES2159678T3 (es) 1991-12-18 2001-10-16 Minnesota Mining & Mfg Formulaciones de aerosol en suspension.
US5756071A (en) * 1992-06-03 1998-05-26 Arrowdean Limited Method for nasally administering aerosols of therapeutic agents to enhance penetration of the blood brain barrier
US5368842A (en) * 1992-10-29 1994-11-29 The Gillette Company High efficacy aerosol antiperspirant composition
TW402506B (en) 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
JP4155594B2 (ja) 1994-12-22 2008-09-24 アストラゼネカ・アクチエボラーグ エアゾール製剤
HU218940B (hu) * 1994-12-22 2001-01-29 Astra Aktiebolag Paratiroid hormont (PHT) tartalmazó, inhalációs célra szolgáló gyógyszerkészítmény, eljárás előállítására, alkalmazása inhalációs készülék töltésére és ezt tartalmazó inhalációs készülék
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6461591B1 (en) 1997-02-05 2002-10-08 Jago Research Ag Medical aerosol formulations
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6946117B1 (en) 1997-09-29 2005-09-20 Nektar Therapeutics Stabilized preparations for use in nebulizers
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20010006939A1 (en) * 1997-10-03 2001-07-05 Ralph W. Niven Secretory leukocyte protease inhibitor dry powder pharmaceutical compositions
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6585958B1 (en) 1998-07-24 2003-07-01 Jago Research Ag Medicinal aerosol formulations
DK1102579T3 (da) 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
ES2364636T3 (es) 2001-12-19 2011-09-08 Novartis Ag Administración pulmonar de aminoglucósidos.
US7582284B2 (en) 2002-04-17 2009-09-01 Nektar Therapeutics Particulate materials
EP1811981B1 (fr) * 2004-10-12 2008-08-13 Merck Generics (UK) Limited Procede pour la preparation d'une suspension a pulveriser, caracterise en ce que les particules sont formees a l'interieur du flacon d'aerosol
EP1949891A1 (fr) 2004-10-12 2008-07-30 Generics (UK) Limited Procédé pour la préparation de formules à suspension pour aérosol, caractérisé en ce que les particles soient formées par précipitation à l'intérieur d'un récipient
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
PL1901749T3 (pl) 2005-05-18 2017-04-28 Horizon Orphan Llc Fluorochinolony w aerozolu i ich zastosowania
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
US20070286814A1 (en) * 2006-06-12 2007-12-13 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
DK2425820T3 (en) 2007-02-11 2015-07-13 Map Pharmaceuticals Inc A method for the therapeutic administration of DHE in order to enable quick relief of migraine, while minimizing the adverse event profile
US8629139B2 (en) 2008-10-07 2014-01-14 Mpex Pharmaceuticals, Inc. Topical use of Levofloxacin for reducing lung inflammation
CA2739897C (fr) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Formulations a base de fluoroquinolone sous forme d'aerosol pour une pharmacocinetique amelioree
EP2473170B1 (fr) 2009-09-04 2019-06-19 Horizon Orphan LLC Utilisation de lévofloxacine en aérosol pour traiter la fibrose kystique
EP4059499A1 (fr) 2011-01-31 2022-09-21 Avalyn Pharma Inc. Composés analogues de pyridone et de pirfénidone en aérosol, et leurs utilisations
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
JP6799201B2 (ja) 2013-07-31 2020-12-16 アヴァリン ファーマ インク． エアロゾルチロシンキナーゼ阻害剤の化合物、及びその使用
JP7066321B2 (ja) 2014-01-10 2022-05-13 アヴァリン ファーマ インク． エアロゾルのピルフェニドン及びピリドンのアナログの化合物、及び、その使用
GB2604314A (en) 2017-09-22 2022-09-07 Nerudia Ltd Device, system and method
WO2022240897A1 (fr) 2021-05-10 2022-11-17 Sepelo Therapeutics, Llc Composition pharmaceutique comprenant de la délafloxacine destinée à être administrée dans le poumon
WO2023028364A1 (fr) 2021-08-27 2023-03-02 Sepelo Therapeutics, Llc Compositions ciblées et leurs utilisations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2440915A (en) * 1946-01-03 1948-05-04 Roberts Mfg Co Process for producing aerosols
US2524590A (en) * 1946-04-22 1950-10-03 Carsten F Boe Emulsion containing a liquefied propellant gas under pressure and method of spraying same
US2594296A (en) * 1948-06-24 1952-04-29 Aerosol Corp Lobeline aerosol dilating medicament
US2728495A (en) * 1951-04-19 1955-12-27 Little Inc A Liquid dispensing device and composition therefor
GB764862A (en) * 1953-02-16 1957-01-02 Midland Silicones Ltd An article for dispensing organosilicon compounds
US2959325A (en) * 1954-04-29 1960-11-08 Risdon Mfg Co Method and apparatus for dispensing dry powders
US2782975A (en) * 1955-04-20 1957-02-26 American Cyanamid Co Sprayable amorphous antibiotic composition, pressurized container with same, and method of preparing

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1170909B (de) * 1961-02-17 1964-05-27 Specialties Dev Corp Selbsttreibendes Gemisch
FR2424740A1 (fr) * 1978-02-06 1979-11-30 Fresenius Chem Pharm Ind Sels metalliques de sulfadiazine en fines particules, leur procede de preparation et preparations pharmaceutiques les contenant

Also Published As

Publication number Publication date
DE1178975B (de) 1964-10-01
GB837465A (en) 1960-06-15
NL106832C (fr) 1963-12-16
NL224547A (fr)
BE556587A (fr) 1957-04-11
US3014844A (en) 1961-12-26

Similar Documents

Publication Publication Date Title
FR1228811A (fr) Composition auto-propulsante pour la distribution de poudre
CH392880A (fr) Composition de revêtement
CH423100A (fr) Composition de revêtement pour médicaments
FR1205405A (fr) Composition pour revêtement
FR1175581A (fr) Compositions pour peintures
BE601603Q (fr) Matières réfractaires
FR1158881A (fr) Compositions pour enduits
FR1167124A (fr) Revêtement protecteur pour matières cellulaires
FR70958E (fr) Enduit pour revêtement
FR1187398A (fr) Réacteur à poudre perfectionné pour projectiles autopropulsés
CH343850A (fr) Réacteur à poudre pour projectile auto-propulsé
FR1212947A (fr) Transporteur pour halles de coulée
FR1170562A (fr) Piedroit pour mines
FR1131221A (fr) Composition pyrotechnique
FR1122567A (fr) Tablier
IE21844L (en) Pharmaceutical composition
FR1190369A (fr) Mélangeur pour la métallurgie
CA516651A (fr) Tablier a cordon d'attache
FR1182863A (fr) Compositions pour ferrites
ES46067Y (es) Ladrillo perfeccionado
FR1177487A (fr) Composition réfractaire
FR1149288A (fr) Composition de plâtre
CA536276A (fr) Moulage de matiere en fusion
FR1166473A (fr) Hourdis pour planchers
BR5793773D0 (pt) Composicao de materia